BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vitiello A, Ferrara F. Pharmacological agents to therapeutic treatment of cardiac injury caused by Covid-19. Life Sci 2020;262:118510. [PMID: 32991879 DOI: 10.1016/j.lfs.2020.118510] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 11.5] [Reference Citation Analysis]
Number Citing Articles
1 Vitiello A, Ferrara F. Pharmacotherapy Based on ACE2 Targeting and COVID-19 Infection. Int J Mol Sci 2022;23:6644. [PMID: 35743089 DOI: 10.3390/ijms23126644] [Reference Citation Analysis]
2 Vitiello A, Ferrara F, Zovi A, Trama U, Boccellino M. Pregnancy and COVID-19, focus on vaccine and pharmacological treatment. Journal of Reproductive Immunology 2022. [DOI: 10.1016/j.jri.2022.103630] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ning Q, Wu D, Wang X, Xi D, Chen T, Chen G, Wang H, Lu H, Wang M, Zhu L, Hu J, Liu T, Ma K, Han M, Luo X. The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication. Signal Transduct Target Ther 2022;7:57. [PMID: 35197452 DOI: 10.1038/s41392-022-00907-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
4 Scarlat G, Dona B, Procopiescu B, Stoian M. Post-Covid-19 Immunological Disorder: A Possible Pathological Entity in a 43 Year Old Man. Internal Medicine 2022;19:77-94. [DOI: 10.2478/inmed-2022-0210] [Reference Citation Analysis]
5 Wang AYL. Modified mRNA-Based Vaccines Against Coronavirus Disease 2019. Cell Transplant 2022;31:9636897221090259. [PMID: 35438579 DOI: 10.1177/09636897221090259] [Reference Citation Analysis]
6 Vitiello A, Ferrara F. Physiopathology and prospectives for therapeutic treatment of pulmonary fibrotic state in COVID-19 patients. Curr Res Pharmacol Drug Discov 2021;2:100056. [PMID: 34870154 DOI: 10.1016/j.crphar.2021.100056] [Reference Citation Analysis]
7 Vitiello A, Ferrara F. Commentary of the mRNA vaccines COVID-19. Asian J Pharm Sci 2021;16:531-2. [PMID: 34849160 DOI: 10.1016/j.ajps.2021.05.004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Vitiello A, Ferrara F. Perspectives of association Baricitinib/Remdesivir for adults with Covid-19 infection. Mol Biol Rep 2021. [PMID: 34839450 DOI: 10.1007/s11033-021-06888-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Vitiello A, Ferrara F. Risk of drug-induced cardiac arrhythmia during COVID-19 therapeutic treatment. Egypt Heart J 2021;73:103. [PMID: 34792677 DOI: 10.1186/s43044-021-00228-8] [Reference Citation Analysis]
10 Vitiello A, La Porta R, D'Aiuto V, Ferrara F. The risks of liver injury in COVID-19 patients and pharmacological management to reduce or prevent the damage induced. Egypt Liver J 2021;11:11. [PMID: 34777865 DOI: 10.1186/s43066-021-00082-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
11 Vitiello A, Troiano V, La Porta R. What will be the role of molnupiravir in the treatment of COVID-19 infection? Drugs Ther Perspect 2021;:1-2. [PMID: 34754175 DOI: 10.1007/s40267-021-00879-2] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
12 Vitiello A, Ferrara F. A short focus, azithromycin in the treatment of respiratory viral infection COVID-19: efficacy or inefficacy? Immunol Res 2021. [PMID: 34739696 DOI: 10.1007/s12026-021-09244-x] [Reference Citation Analysis]
13 Vitiello A, Ferrara F. Low Molecular Weight Heparin, Anti-inflammatory/Immunoregulatory and Antiviral Effects, a Short Update. Cardiovasc Drugs Ther 2021. [PMID: 34460031 DOI: 10.1007/s10557-021-07251-6] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
14 Vitiello A, Ferrara F. Plausible Positive Effects of Statins in COVID-19 Patient. Cardiovasc Toxicol 2021;21:781-9. [PMID: 34255300 DOI: 10.1007/s12012-021-09674-x] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
15 Arjmand B, Alavi-Moghadam S, Parhizkar Roudsari P, Rezaei-Tavirani M, Rahim F, Gilany K, Mohamadi-Jahani F, Adibi H, Larijani B. COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions. Front Cell Dev Biol 2021;9:675310. [PMID: 34195193 DOI: 10.3389/fcell.2021.675310] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
16 Ferrara F, Santilli P, Vitiello A, Forte G, D'Aiuto V. Logistics management provides greater efficiency, governance and compliance. Int J Clin Pharm 2021. [PMID: 34121155 DOI: 10.1007/s11096-021-01283-6] [Reference Citation Analysis]
17 Vitiello A, Ferrara F. Brief review of the mRNA vaccines COVID-19. Inflammopharmacology 2021;29:645-9. [PMID: 33932192 DOI: 10.1007/s10787-021-00811-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
18 Vitiello A, Ferrara F. Pharmacological agents modifying the renin angiotensin and natriuretic peptide systems in COVID-19 patients. Wien Klin Wochenschr 2021. [PMID: 33877436 DOI: 10.1007/s00508-021-01855-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
19 Silva Andrade B, Siqueira S, de Assis Soares WR, de Souza Rangel F, Santos NO, Dos Santos Freitas A, Ribeiro da Silveira P, Tiwari S, Alzahrani KJ, Góes-Neto A, Azevedo V, Ghosh P, Barh D. Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms. Viruses 2021;13:700. [PMID: 33919537 DOI: 10.3390/v13040700] [Cited by in Crossref: 5] [Cited by in F6Publishing: 59] [Article Influence: 5.0] [Reference Citation Analysis]
20 Ferrara F, Vitiello A. The advantages of drug treatment with statins in patients with SARS-CoV-2 infection. Wien Klin Wochenschr 2021. [PMID: 33779831 DOI: 10.1007/s00508-021-01845-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Vitiello A, Ferrara F. Colchicine and SARS-CoV-2: Management of the hyperinflammatory state. Respir Med 2021;178:106322. [PMID: 33550151 DOI: 10.1016/j.rmed.2021.106322] [Cited by in Crossref: 11] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
22 Vitiello A, La Porta R, D'Aiuto V, Ferrara F. Pharmacological approach for the reduction of inflammatory and prothrombotic hyperactive state in COVID-19 positive patients by acting on complement cascade. Hum Immunol 2021;82:264-9. [PMID: 33632561 DOI: 10.1016/j.humimm.2021.01.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
23 Ferrara F, Vitiello A. Efficacy of synthetic glucocorticoids in COVID-19 endothelites. Naunyn Schmiedebergs Arch Pharmacol 2021;394:1003-7. [PMID: 33443616 DOI: 10.1007/s00210-021-02049-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 22] [Article Influence: 14.0] [Reference Citation Analysis]
24 Vitiello A, Ferrara F, Porta R. Remdesivir and COVID-19 infection, therapeutic benefits or unnecessary risks? Ir J Med Sci 2021. [PMID: 33433843 DOI: 10.1007/s11845-020-02482-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
25 Vitiello A, La Porta R, Ferrara F. Scientific hypothesis and rational pharmacological for the use of sacubitril/valsartan in cardiac damage caused by COVID-19. Med Hypotheses 2021;147:110486. [PMID: 33460992 DOI: 10.1016/j.mehy.2021.110486] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
26 Vitiello A, Ferrara F. Antidiabetes Agents against Sars-Cov-2 Infection. SN Compr Clin Med 2020;:1-4. [PMID: 33134845 DOI: 10.1007/s42399-020-00608-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]